Cargando…
Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes
p-Tyramine is an archetypal member of the endogenous family of monoamines known as trace amines, and is one of the endogenous agonists for trace amine-associated receptor (TAAR)1. While much work has focused on the function of TAAR1, very little is known about the regulation of the endogenous agonis...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128819/ https://www.ncbi.nlm.nih.gov/pubmed/27901065 http://dx.doi.org/10.1038/srep38006 |
_version_ | 1782470481005248512 |
---|---|
author | Berry, Mark D. Hart, Shannon Pryor, Anthony R. Hunter, Samantha Gardiner, Danielle |
author_facet | Berry, Mark D. Hart, Shannon Pryor, Anthony R. Hunter, Samantha Gardiner, Danielle |
author_sort | Berry, Mark D. |
collection | PubMed |
description | p-Tyramine is an archetypal member of the endogenous family of monoamines known as trace amines, and is one of the endogenous agonists for trace amine-associated receptor (TAAR)1. While much work has focused on the function of TAAR1, very little is known about the regulation of the endogenous agonists. We have previously reported that p-tyramine readily crosses lipid bilayers and that its release from synaptosomes is non-exocytotic. Such release, however, showed characteristics of modification by one or more transporters. Here we provide the first characterization of such a transporter. Using frontal cortical and striatal synaptosomes we show that p-tyramine passage across synaptosome membranes is not modified by selective inhibition of either the dopamine, noradrenaline or 5-HT transporters. In contrast, inhibition of uptake-2 transporters significantly slowed p-tyramine re-uptake. Using inhibitors of varying selectivity, we identify Organic Cation Transporter 2 (OCT2; SLC22A2) as mediating high affinity uptake of p-tyramine at physiologically relevant concentrations. Further, we confirm the presence of OCT2 protein in synaptosomes. These results provide the first identification of a high affinity neuronal transporter for p-tyramine, and also confirm the recently described localization of OCT2 in pre-synaptic terminals. |
format | Online Article Text |
id | pubmed-5128819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51288192016-12-09 Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes Berry, Mark D. Hart, Shannon Pryor, Anthony R. Hunter, Samantha Gardiner, Danielle Sci Rep Article p-Tyramine is an archetypal member of the endogenous family of monoamines known as trace amines, and is one of the endogenous agonists for trace amine-associated receptor (TAAR)1. While much work has focused on the function of TAAR1, very little is known about the regulation of the endogenous agonists. We have previously reported that p-tyramine readily crosses lipid bilayers and that its release from synaptosomes is non-exocytotic. Such release, however, showed characteristics of modification by one or more transporters. Here we provide the first characterization of such a transporter. Using frontal cortical and striatal synaptosomes we show that p-tyramine passage across synaptosome membranes is not modified by selective inhibition of either the dopamine, noradrenaline or 5-HT transporters. In contrast, inhibition of uptake-2 transporters significantly slowed p-tyramine re-uptake. Using inhibitors of varying selectivity, we identify Organic Cation Transporter 2 (OCT2; SLC22A2) as mediating high affinity uptake of p-tyramine at physiologically relevant concentrations. Further, we confirm the presence of OCT2 protein in synaptosomes. These results provide the first identification of a high affinity neuronal transporter for p-tyramine, and also confirm the recently described localization of OCT2 in pre-synaptic terminals. Nature Publishing Group 2016-11-30 /pmc/articles/PMC5128819/ /pubmed/27901065 http://dx.doi.org/10.1038/srep38006 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Berry, Mark D. Hart, Shannon Pryor, Anthony R. Hunter, Samantha Gardiner, Danielle Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes |
title | Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes |
title_full | Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes |
title_fullStr | Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes |
title_full_unstemmed | Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes |
title_short | Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes |
title_sort | pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128819/ https://www.ncbi.nlm.nih.gov/pubmed/27901065 http://dx.doi.org/10.1038/srep38006 |
work_keys_str_mv | AT berrymarkd pharmacologicalcharacterizationofahighaffinityptyraminetransporterinratbrainsynaptosomes AT hartshannon pharmacologicalcharacterizationofahighaffinityptyraminetransporterinratbrainsynaptosomes AT pryoranthonyr pharmacologicalcharacterizationofahighaffinityptyraminetransporterinratbrainsynaptosomes AT huntersamantha pharmacologicalcharacterizationofahighaffinityptyraminetransporterinratbrainsynaptosomes AT gardinerdanielle pharmacologicalcharacterizationofahighaffinityptyraminetransporterinratbrainsynaptosomes |